Bevacizumab Monotherapy as Salvage Therapy for Advanced clear cell Renal Cell Carcinoma (ccRCC) Pretreated with Targeted Drugs

Bevacizumab has shown benefit in the first line setting in combination with interferon; however, data on use as monotherapy are limited. This retrospective analysis of 71 patients assesses the efficacy of bevacizumab monotherapy in patients who progressed on other targeted drugs. Bevacizumab monothe...

Full description

Saved in:
Bibliographic Details
Published in:Clin Genitourin Cancer
Main Authors: Lee, Chung-Han, Hötker, Andreas M., Voss, Martin H., Feldman, Darren R., Woo, Kaitlin M., Patil, Sujata, Coskey, Devyn T., Akin, Oguz, Hsieh, James J., Motzer, Robert J.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965701/
https://ncbi.nlm.nih.gov/pubmed/26404107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.07.010
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items